TrialJapanese journal of ophthalmology2021

Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study.

Osamu Hieda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.